Overexpression of enhanced yellow fluorescent protein fused with Channelrhodopsin‐2 causes contractile dysfunction in skeletal muscle
Syeda N Lamia, Carol S Davis, Peter C D Macpherson, T Brad Willingham, Yingfan Zhang, Chengyu Liu, Leanne Iannucci, Elahe Ganji, Desmond Harden, Iman Bhattacharya, Adam C Abraham, Susan V Brooks, Brian Glancy, Megan L Killian · 2024
Read Overexpression of enhanced yellow fluorescent protein fused with Channelrhodopsin‐2 causes contractile dysfunction in skeletal muscle by Syeda N Lamia, Carol S Davis, Peter C D Macpherson, T Brad Willingham, Yingfan Zhang, Chengyu Liu, Leanne Iannucci, Elahe Ganji, Desmond Harden, Iman Bhattacharya, Adam C Abraham, Susan V Brooks, Brian Glancy, Megan L Killian (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11586894.txt.
Description
Skeletal muscle activation using optogenetics has emerged as a promising technique for inducing noninvasive muscle contraction and assessing muscle function both in vivo and in vitro. Transgenic mice overexpressing the optogenetic fusion protein, Channelrhodopsin 2‐EYFP (ChR2‐EYFP) in skeletal muscle are widely used; however, overexpression of fluorescent proteins can negatively impact the functionality of activable tissues.
Catalog record
| CREATOR | Syeda N Lamia, Carol S Davis, Peter C D Macpherson, T Brad Willingham, Yingfan Zhang, Chengyu Liu, Leanne Iannucci, Elahe Ganji, Desmond Harden, Iman Bhattacharya, Adam C Abraham, Susan V Brooks, Brian Glancy, Megan L Killian |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |